Implementing less invasive surfactant administration in Nigeria: a prospective cohort study with a retrospective matched control

Read full text Summarise with VIRAT
Authors: Mariya Mukhtar‐Yola, Zubaida Ladan Farouk, Hadiza Ashiru Usman, Angela Anene Okolo, Joseph Ajanwenyi, Efe Erhinyaye Omoyibo, Chineye Umukoro, Chinyere Ezeaka, Iretiola Fajolu, Olaolu Moronkola, Beatrice Nkolika Ezenwa, Amsa B. Mairami
+8 more L. J. Mshelia, Ikechukwu Richard Okonkwo, Olufemi K. Olaniyi, Kenechukwu Kosisochukwu Iloh, Chinelo E. Obiora-Izuka, Grace Agu, Hannah Bolte, Osayame A. Ekhaguere
Cited by: 0
References: 29

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background Evidence on the benefits of less invasive surfactant administration (LISA) for preterm survival in low- and middle-income countries (LMICs) is limited. The study aimed to determine the feasibility of implementing LISA in tertiary referral facilities in Nigeria and determine its potential impact on preterm survival. Method The study utilized a prospective cohort with a retrospective matched control design enrolling preterm infants ≤2000 g at birth who received LISA in six Nigerian NICUs between July 2023 and March 2025 and matched them 1:1 to a historical registry cohort managed with CPAP alone, recruited from three of the same sites between 2018 and 2021. Matching variables included birth weight, gestational age, place of birth, and Downes respiratory distress score. Excluded infants included those with major congenital anomalies, active pulmonary hemorrhage, and pre-enrollment intubation. Multivariate analyses examined the association between LISA and mortality at 72 h and hospital disposition. Feasibility was assessed by the procedural success and complication rate. Findings Of the 341 matched subjects, at 72 h of life, death occurred in 55 infants (16%) in the LISA cohort and 115 (34%) in the historical cohort (adjusted odds ratio [aOR], 0.34, 95% confidence interval [CI], 0.23–0.50). At hospital disposition, death occurred in 145 infants (43%) in the LISA cohort and 208 (61%) in the historical cohort (aOR, 0.37, 95% CI, 0.26–0.54). The LISA procedures were successfully performed in 340 (99.7%) of cases. The most common complication was oxygen desaturation (42 [12.3%]). One procedure-related death (0.3%) occurred. Interpretation Implementing LISA in tertiary NICUs in Nigeria was feasible and associated with improved preterm survival rates and few complications. Funding BLES Biochemicals Inc.

Fields of Study & Subjects

Neonatal Respiratory Health Research Infant Development and Preterm Care Respiratory Support and Mechanisms

Publication details

Journal / source
The Lancet Regional Health - Africa
Volume
3
Pages
100044–100044
Publication date
26 March 2026
Language
EN